Rights and permissions
About this article
Cite this article
Implications of recent trials for NCEP ATP III guidelines. Inpharma Wkly. 1456, 3 (2004). https://doi.org/10.2165/00128413-200414560-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414560-00003